Leonteq Securities AG’s BeOne Medicines Ltd ONC Stock Holding History

Leonteq Securities AG’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.9K	Buy	133 +31	+30%	+$9.13K	﹤0.01%	858
2026 Q1	$30.3K	Sell	102 -14	-12%	-$4.53K	﹤0.01%	938
2025 Q4	$35.2K	Sell	116 -13	-10%	-$4.25K	﹤0.01%	1009
2025 Q3	$44K	Sell	129 -40	-24%	-$12.1K	﹤0.01%	905
2025 Q2	$40.9K	Sell	169 -7	-4%	-$1.72K	﹤0.01%	882
2025 Q1	$47.9K	Buy	176 +35	+25%	+$8.18K	﹤0.01%	838
2024 Q4	$26K	Buy	+141	New	+$28.8K	﹤0.01%	932
2023 Q2	–	Sell	-128	Closed	-$27.6K	–	1324
2023 Q1	$27.6K	Sell	128 -39	-23%	-$9.36K	﹤0.01%	898
2022 Q4	$36.7K	Hold	167	–	–	﹤0.01%	881
2022 Q3	$22.5K	Hold	167	–	–	﹤0.01%	938
2022 Q2	$27K	Hold	167	–	–	﹤0.01%	942
2022 Q1	$31.5K	Hold	167	–	–	﹤0.01%	946
2021 Q4	$45.2K	Hold	167	–	–	﹤0.01%	922
2021 Q3	$60.6K	Sell	167 -224	-57%	-$73.2K	﹤0.01%	815
2021 Q2	$134K	Sell	391 -1,120	-74%	-$371K	0.01%	657
2021 Q1	$526K	Sell	1,511 -1,842	-55%	-$610K	0.03%	377
2020 Q4	$866K	Buy	+3,353	New	+$923K	0.05%	308

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Leonteq Securities AG's ONC Position: Q2 2026 in Review

Leonteq Securities AG increased its BeOne Medicines Ltd (ONC) stake by 30% in Q2 2026, buying an estimated $9.13K and bringing the position to 133 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Leonteq Securities AG first reported a position in ONC in Q4 2020 and has held it in 17 quarters since. The position peaked at $866K in Q4 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Leonteq Securities AG held 133 shares of BeOne Medicines Ltd worth $37.9K as of Q2 2026.
Leonteq Securities AG bought 31 BeOne Medicines Ltd shares in Q2 2026, an estimated $9.13K.
BeOne Medicines Ltd made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #858 holding.
Leonteq Securities AG first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 17 quarters since.
Leonteq Securities AG's BeOne Medicines Ltd position peaked at $866K in Q4 2020.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.